TrialBritish journal of clinical pharmacology2022

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP.

Vibeke Miller Breinholt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.